ALK and cholangiocarcinoma: cMet and ALK expression was investigated in six CCA cell lines; four cell lines were derived from patients with OV infection, namely, KKU-M055, KKU-M213, KKU-M156, and HuCCA-1, and two lines from OV-negative patients, RBE and TFK-1.